{
  "docId": "019de071-dcb4-71ce-82aa-3fde96763369",
  "docSlug": "c85401f3daf1ffc5cb0e20a3335252d7",
  "documentTitle": "BenevolentAI | SPAC Presentation Deck | 42 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 24,
  "pageCount": 42,
  "prevPage": 23,
  "nextPage": 25,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide outlines a two-part clinical trial process with a mid-trial review phase.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-dcb4-71ce-82aa-3fde96763369/24",
  "deckHref": "/decks/019de071-dcb4-71ce-82aa-3fde96763369",
  "deckJsonHref": "/decks/019de071-dcb4-71ce-82aa-3fde96763369.json",
  "deckAnchorHref": "/decks/019de071-dcb4-71ce-82aa-3fde96763369#slide-24",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.82
      },
      "kind": "callout",
      "text": "Our intention is to out-licence development and commercialisation of BEN-2293 following completion of this trial, with good interest from key Big Pharma and Dermatology specialists as potential partners",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6ea5ae20-9319-4d1b-accc-34352de937dd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Part A (1-4) -> Review -> Part B",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "712014e2-6ab9-4ee0-a79a-81026f336957",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "list",
      "text": "Part A: First in Human Dose Escalation. 3/4 cohorts completed. 8 patients per cohort. Safety, Tolerability, PK focus.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1423e9e9-2a33-479d-a1cf-55ae920090f5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.65,
        "y": 0.45
      },
      "kind": "list",
      "text": "Part B: Efficacy Cohort(s). Full data mid 2022. 30-45 patients per arm. Efficacy focus.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50bcde83-29a1-473a-9cd0-9cb90d8343b8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.24,
        "x": 0.38,
        "y": 0.45
      },
      "kind": "list",
      "text": "Review: Late 2021. Part A efficacy readout, statistical modelling, finalise Part B design.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c2dc01c2-253a-4bdc-b46f-17776ae6cc54",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "BEN-2293 is progressing in an adaptive Phase I/II clinical study, with full data expected in mid 2022",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "29509029-1b67-4550-a47f-909bc50064ec",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "124ad5ea-946e-4d5d-a09f-3d6e0d05bb56",
      "evidence": "The slide uses a sequential flow diagram to represent clinical trial phases.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 24,
      "from": 21,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "1f7e984e-ea28-4a79-851c-c2fb54c3288f",
      "evidence": "The deck presents BenevolentAI's portfolio and progress",
      "position": 1,
      "objective": "Showcase quick wins and big bets in BenevolentAI's portfolio",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}